SCHEMBL27445903

SCHEMBL27445903

COc1nc(C(C)C)cc2c1ncn2C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
CDK1 P06493 5/20 0.38
APAF1 O14727 4/20 0.38
TDP1 Q9NUW8 2/20 0.36
CCNB1 P14635 2/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
CASP6 P55212 1/20 0.34
CCNB2 O95067 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
TDP2 O95551 1/20 0.34
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27445898 0.79 L3MBTL1 (0.42) L3MBTL1SMN1; SMN2CDK1APAF1TDP1
SCHEMBL22650407 0.72 L3MBTL1 (0.37) L3MBTL1SMN1; SMN2CDK1APAF1TDP1
SCHEMBL22650503 0.72 MAPK14 (0.46) L3MBTL1SMN1; SMN2CDK1CCNB1CCNE1
SCHEMBL22650721 0.70 SMN1; SMN2 (0.34) L3MBTL1SMN1; SMN2CDK2CDK5CDK5R1
SCHEMBL15763397 0.69 CDK1 (0.47) CDK1TDP1CCNB1CCNE1CDK2
SCHEMBL22700168 0.68 CDK2 (0.51) CDK1TDP1CCNB1CCNE1CDK2
SCHEMBL12451372 0.68 CDK1 (0.67) CDK1TDP1CCNB1CCNE1CDK2
SCHEMBL31380703 0.68 CDK2 (0.51) CDK1TDP1CCNB1CCNE1CDK2
SCHEMBL23547309 0.67 SMN1; SMN2 (0.50) L3MBTL1SMN1; SMN2CDK1APAF1CCNB1
SCHEMBL5450947 0.66 PDE1A (0.45) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024119122-A1 CDK INHIBITORS AND METHODS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-06-06 WO disclosed